Vaccines

14 Mar 2008 Greer Reports Favorable Results of Phase IIb Clinical Trial of Short Ragweed Sublingual-Oral Immunotherapy at American Academy of Allergy Asthma and Immunology Annual Meeting
12 Mar 2008 Opexa Therapeutics Announces Completion of Mid Study DescriptiveAnalysis on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
11 Mar 2008 Inovio Biomedical's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy
11 Mar 2008 Nventa Enrolls and Initiates Dosing of Final Cohort in HSPE7 Phase 1 Cervical Dysplasia Trial
10 Mar 2008 Oxford Biomedica completes patient recruitment for Phase III trist study of Trovax (R) in renal cancer
10 Mar 2008 Genitope Corporation to Suspend Development of MyVax(R) Personalized Immunotherapy
07 Mar 2008 THE LANCET publishes phase IIa study results with Cytos Biotechnology’s hypertension vaccine CYT006-AngQb
27 Feb 2008 Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
27 Feb 2008 Intercell completes Phase I clinical trial for improved seasonal Flu vaccine formulated with IC31(R)
25 Feb 2008 Acambis initiates pre-clinical testing with herpes vaccine from Harvard Medical School
25 Feb 2008 GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
20 Feb 2008 Oxford Biomedica announces data safety monitoring board recommendation to continue TroVax (R) Phase III trist study
20 Feb 2008 GlaxoSmithKline receives favourable recommendation by FDA Advisory Committee for Rotarix(R)
15 Feb 2008 Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
14 Feb 2008 Vaccine formulated with Intercell's adjuvant IC31(R) part of a broader collaboration to fight TB
12 Feb 2008 Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
07 Feb 2008 Intercell's therapeutic Hepatitis C vaccine meets primary endpoints in Phase II
07 Feb 2008 GeoVax Labs, Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented at Retrovirus Conference
22 Jan 2008 Medicago’s Pandemic Flu Vaccine Provides 100% Protection in Mice at Low Doses
17 Jan 2008 ICLL receives manufacturer's licence for future commercial manufacturing of its JE vaccine
16 Jan 2008 Intercell and PATH Malaria Vaccine Initiative Announce New Collaboration for Vaccine against Malaria
15 Jan 2008 Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
14 Jan 2008 Nventa completes evaluation of second cohort in HSPE7 Phase 1 cervical dysplasia trial
09 Jan 2008 New data show Menveo(TM) to be the first quadrivalent meningococcal vaccine to provide immunogenicity in infants
07 Jan 2008 Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top